Drug Science is the leading independent scientific body on drugs in the UK. We work to provide clear, evidence-based information without political or commercial interference.

In this webinar, we discuss how festivals can be improved as they return from their 2020 hiatus. Drug use at festivals is unsurprisingly high, and always has been, but organisers are often battling against drug policy in their efforts to improve the safety of festival-goers with harm reduction techniques such as…

In this update, find out what GPs think about medical cannabis as we celebrate 1000 patients joining Project Twenty21. We share updates on the project, including new clinics and data insights, as well as initiatives working to improve medical cannabis in the UK. We also announce new events related to the…

There is no defined road to legalising psychedelics, but there are many options available. Ismail Lourido Ali, of MAPS, discusses the important nuances in this Drug Science webinar on expanding access to psychedelics. Due to the recent progress of medical cannabis legalisation, many expect psychedelics to follow a similar path of…

This is the full recording of our 4th Women in Psychedelic Science event, hosted in June. Featuring experts working at the cutting edge of psychedelic science and in related fieldwork. Psychedelic medicine: from lab findings to therapeutic applications Dr Kim Kuypers Kim PC Kuypers (PhD) is affiliated as an Associate Professor…

Could psilocybin be used to treat OCD? Psilocybin is currently being researched as a treatment for OCD by Drug Science founder, Prof David Nutt, at the Centre for Psychedelic Research. In this Drug Science webinar, Dr Nick Sireau provides an overview of OCD and the new research being launched into psilocybin…